mitomycin has been researched along with cyclosporine in 34 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (17.65) | 18.2507 |
2000's | 14 (41.18) | 29.6817 |
2010's | 14 (41.18) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bacsó, Z; Cianfriglia, M; Fenyvesi, F; Goda, K; Kappelmayer, J; Lustyik, G; Nagy, H; Szabó, G; Szilasi, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
Avery, VM; Sykes, ML | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Smyth, MJ | 1 |
Norihisa, Y; Ortaldo, JR; Smyth, MJ | 1 |
Bernardi, P; Szabó, I; Zoratti, M | 1 |
Ito, K; Komatsu, Y | 1 |
Maksymowicz, M; Olszewski, WL | 1 |
George, JN; Medina, PJ; Sipols, JM | 1 |
Gao, J; Zhai, Z | 1 |
Akyol, N; Cobanoglu, B; Demir, T; Ulaş, F | 1 |
Deschl, U; Platz, SJ; Schleger, C | 1 |
Szaflik, J; Zaleska-Zmijewska, A | 1 |
Aizawa, Y; Fuse, I; Niwano, H; Sato, N; Seki, Y; Takahashi, H; Tanabe, N; Toba, K | 1 |
Garweg, JG; Goldblum, D; Wegmann-Burns, M | 1 |
Boehnke, M; Flueckiger, F; Garweg, JG; Halberstadt, M; Kodjikian, L | 1 |
Allen, RC; Crouch, ER; Lattanzio, FA; Mitrev, PV; Williams, PB | 1 |
Bennett, C; Zakarija, A | 1 |
Erbilen, E; Tunc, M | 1 |
Cukur, S; Dosoglu, M; Gezen, F; Is, M; Yildiz, KH | 1 |
Buron, F; Héquet, O; Malcus, C; Morelon, E; Moulin, FT; Perrin, H | 1 |
Farid, SF; Zaki, AA | 1 |
George, RE; Sugandhi, P | 1 |
Birnbaum, F; Böhringer, D; Eberwein, P; Reinhard, T; Schwartzkopff, J | 1 |
Zarbin, MA | 1 |
Angus, PW; Chin, R; Jia, Z; Lim, EJ; Nachbur, U; Silke, J; Torresi, J | 1 |
Choi, S; Hwang, S | 1 |
Alcalde, I; Alonso, MJ; Bech, F; Csaba, N; de la Fuente, M; Íñigo-Portugués, A; Merayo-Lloves, J; Reimondez-Troitiño, S; Riestra, AC | 1 |
Diehm, Y; Dittmar, L; Fischer, S; Gebhard, MM; Hetzel, O; Kiefer, J; Kleist, C; Kneser, U; Neubrech, F; Radu, CA; Terness, P | 1 |
Arruda, GV; Fonseca, EC; Rocha, EM | 1 |
8 review(s) available for mitomycin and cyclosporine
Article | Year |
---|---|
Approaches to protozoan drug discovery: phenotypic screening.
Topics: Drug Discovery; Humans; Molecular Structure; Neglected Diseases; Phenotype; Plasmodium falciparum; Protozoan Infections; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosoma cruzi | 2013 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Drug induced hemolytic uremic syndrome].
Topics: Cisplatin; Cocaine; Cyclosporine; Hemolytic-Uremic Syndrome; Heparin; Humans; Mitomycin; Plasma Exchange; Platelet Aggregation Inhibitors; Quinine; Tacrolimus | 1993 |
Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
Topics: Antibiotics, Antineoplastic; Clopidogrel; Cyclosporine; Hemolytic-Uremic Syndrome; Humans; Immunosuppressive Agents; Mitomycin; Muscle Relaxants, Central; Platelet Aggregation Inhibitors; Quinine; Ticlopidine | 2001 |
Advances in experimental studies on albendazole and other drugs against hydatid disease.
Topics: Albendazole; Animals; Anticestodal Agents; Cyclosporine; Drug Therapy, Combination; Echinococcosis; Gerbillinae; Humans; Inosine Pranobex; Ivermectin; Mice; Mitomycin; Rats | 1999 |
[Pharmacological methods improving the effectiveness of filtering procedures].
Topics: Antibiotics, Antineoplastic; Antibodies; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Cyclosporine; Filtering Surgery; Fluorouracil; Glaucoma; Growth Substances; Humans; Mitomycin; Treatment Outcome | 2004 |
Drug-induced thrombotic microangiopathy.
Topics: ADAM Proteins; ADAMTS13 Protein; Antibiotics, Antineoplastic; Cyclosporine; Endothelium, Vascular; Fibrinolytic Agents; Hemolytic-Uremic Syndrome; Humans; Immunosuppressive Agents; Mitomycin; Purpura, Thrombotic Thrombocytopenic; Quinine; Ticlopidine; Treatment Outcome | 2005 |
Comparison among adjuvant treatments for primary pterygium: a network meta-analysis.
Topics: Adjuvants, Immunologic; Alkylating Agents; Chemotherapy, Adjuvant; Conjunctiva; Cyclosporine; Fluorouracil; Humans; Immunosuppressive Agents; Mitomycin; Network Meta-Analysis; Ophthalmic Solutions; Ophthalmologic Surgical Procedures; Pterygium; Randomized Controlled Trials as Topic; Recurrence; Transplantation, Autologous | 2018 |
1 trial(s) available for mitomycin and cyclosporine
Article | Year |
---|---|
A Comparative Study of Topical Mitomycin C, Cyclosporine, and Bevacizumab after Primary Pterygium Surgery.
Topics: Administration, Topical; Aged; Aged, 80 and over; Alkylating Agents; Angiogenesis Inhibitors; Bevacizumab; Cell Count; Combined Modality Therapy; Cyclosporine; Double-Blind Method; Endothelium, Corneal; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Mitomycin; Ophthalmic Solutions; Ophthalmologic Surgical Procedures; Prospective Studies; Pterygium; Recurrence; Vascular Endothelial Growth Factor A | 2015 |
25 other study(ies) available for mitomycin and cyclosporine
Article | Year |
---|---|
Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies.
Topics: Adenosine Triphosphatases; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Calcium Channel Blockers; Cyclosporine; Detergents; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluoresceins; Humans; Ivermectin; Mice; NIH 3T3 Cells; Substrate Specificity | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Mechanisms of cytotoxicity used by human peripheral blood T-cell subsets.
Topics: Bucladesine; CD4 Antigens; CD8 Antigens; Cholera Toxin; Cycloheximide; Cyclosporine; Cytotoxicity, Immunologic; Dactinomycin; Egtazic Acid; Emetine; Humans; Lymphocyte Activation; Mitomycin; T-Lymphocyte Subsets; Tumor Necrosis Factor-alpha | 1992 |
Multiple cytolytic mechanisms displayed by activated human peripheral blood T cell subsets.
Topics: Antigens, Differentiation, T-Lymphocyte; CD3 Complex; CD4-Positive T-Lymphocytes; CD8 Antigens; Cyclosporine; Cytotoxicity, Immunologic; Dactinomycin; Gene Expression; Granzymes; Humans; In Vitro Techniques; Interleukin-2; Lymphocyte Activation; Membrane Glycoproteins; Membrane Proteins; Mitomycin; Perforin; Pore Forming Cytotoxic Proteins; Protein Synthesis Inhibitors; Receptors, Antigen, T-Cell; Serine Endopeptidases; T-Lymphocyte Subsets; T-Lymphocytes, Cytotoxic; Tumor Necrosis Factor-alpha | 1992 |
Modulation of the mitochondrial megachannel by divalent cations and protons.
Topics: Animals; Barium; Calcium; Cations, Divalent; Cyclosporine; Egtazic Acid; Electric Conductivity; Hydrogen-Ion Concentration; Ion Channels; Kinetics; Magnesium; Mitochondria, Liver; Mitomycin; Rats | 1992 |
Cyclosporine control of recipient lymphocyte traffic to the heart allograft.
Topics: Animals; Azides; Chromium Radioisotopes; Cyclosporine; Heart Transplantation; Immunosuppression Therapy; Lymph Nodes; Lymphocyte Transfusion; Lymphocytes; Mitomycin; Rats; Rats, Inbred Strains; Rats, Wistar; Sodium Azide; Transplantation, Homologous; Transplantation, Isogeneic | 1996 |
Ciliary body toxicity of cyclosporin A and octreotide acetate in rabbit eyes: a comparison with mitomycin C and 5-fluorouracil.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Hormonal; Ciliary Body; Cyclosporine; Epithelium; Female; Filtering Surgery; Fluorouracil; Immunosuppressive Agents; Male; Mitomycin; Octreotide; Ophthalmic Solutions; Pigment Epithelium of Eye; Rabbits | 2003 |
Development of an in vitro model for vascular injury with human endothelial cells.
Topics: 3T3 Cells; Amrinone; Animal Testing Alternatives; Animals; Antibiotics, Antineoplastic; Antifibrinolytic Agents; Cell Membrane Permeability; Cell Survival; Cells, Cultured; Cyclosporine; Dose-Response Relationship, Drug; Electric Impedance; Endothelial Cells; Endothelium, Vascular; Epoprostenol; Humans; Immunosuppressive Agents; Injections, Intravenous; Mice; Mitomycin; Models, Biological; Phosphodiesterase Inhibitors; Rolipram; Thromboxane A2; Umbilical Veins; Vitamin K 3 | 2004 |
In vitro effect of cyclosporin A, mitomycin C and prednisolone on cell kinetics in cultured human umbilical vein endothelial cells.
Topics: Blotting, Western; Cell Proliferation; Cells, Cultured; Cyclosporine; Dose-Response Relationship, Drug; Endothelial Cells; Endothelium, Vascular; Enzyme Inhibitors; Flow Cytometry; Humans; Kinetics; Mitomycin; Nucleic Acid Synthesis Inhibitors; Prednisolone; Umbilical Veins | 2005 |
Effects of daunorubicin, mitomycin C, azathioprine and cyclosporin A on human retinal pigmented epithelial, corneal endothelial and conjunctival cell lines.
Topics: Antimetabolites; Azathioprine; Cell Count; Cell Line; Cell Proliferation; Conjunctiva; Cyclosporine; Daunorubicin; Endothelium, Corneal; Epithelial Cells; Fluoresceins; Humans; Immunosuppressive Agents; Mitomycin; Pigment Epithelium of Eye; Propidium | 2006 |
An ex-vivo, whole-globe porcine model of corneoepithelial wound healing tested using immunomodulatory drugs.
Topics: Animals; Cyclosporine; Dexamethasone; Dose-Response Relationship, Drug; Epithelium, Corneal; Mitomycin; Models, Animal; Swine; Wound Healing | 2005 |
Cyclosporin as an adjunct to glaucoma filtration surgery.
Topics: Administration, Topical; Animals; Antibiotics, Antineoplastic; Combined Modality Therapy; Conjunctiva; Cyclosporine; Female; Filtering Surgery; Fistula; Glaucoma; Immunosuppressive Agents; Intraocular Pressure; Intraoperative Care; Mitomycin; Ophthalmic Solutions; Rabbits | 2005 |
Topical cyclosporine-a combined with mitomycin C for conjunctival and corneal squamous cell carcinoma.
Topics: Administration, Topical; Aged; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Conjunctival Neoplasms; Corneal Diseases; Cyclosporine; Drug Therapy, Combination; Eye Neoplasms; Humans; Immunosuppressive Agents; Male; Middle Aged; Mitomycin | 2006 |
Mitomycin C, 5-fluorouracil, and cyclosporin A prevent epidural fibrosis in an experimental laminectomy model.
Topics: Animals; Antibiotics, Antineoplastic; Cell Count; Cyclosporine; Epidural Space; Fibroblasts; Fibrosis; Fluorouracil; Immunosuppressive Agents; Laminectomy; Lumbar Vertebrae; Male; Mitomycin; Models, Animal; Rats; Rats, Wistar | 2007 |
Mesenchymal stem cell and immunosuppressive drug interactions.
Topics: Cell Division; Cyclosporine; Drug Interactions; Humans; Immunosuppressive Agents; Mesenchymal Stem Cells; Mitomycin; Mycophenolic Acid; Sirolimus | 2009 |
Management of intraepithelial and invasive neoplasia of the cornea and conjunctiva: a long-term follow up.
Topics: Aged; Carcinoma in Situ; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Conjunctival Neoplasms; Corneal Diseases; Cyclosporine; Drug Therapy, Combination; Eye Neoplasms; Female; Follow-Up Studies; Humans; Male; Mitomycin; Neoplasm Invasiveness; Ophthalmologic Surgical Procedures; Treatment Outcome | 2009 |
Use of combination therapy of topical mitomycin C and cyclosporine a as an adjunct to surgery for corneal and conjunctival intraepithelial neoplasia and invasive squamous cell carcinoma.
Topics: Administration, Topical; Carcinoma in Situ; Carcinoma, Squamous Cell; Combined Modality Therapy; Conjunctival Neoplasms; Corneal Diseases; Cyclosporine; Drug Therapy, Combination; Humans; Mitomycin; Ophthalmologic Surgical Procedures | 2011 |
Allogenic limbo-keratoplasty with conjunctivoplasty, mitomycin C, and amniotic membrane for bilateral limbal stem cell deficiency.
Topics: Adult; Alkylating Agents; Amnion; Conjunctiva; Corneal Diseases; Cyclosporine; Female; Follow-Up Studies; Graft Survival; Humans; Immunosuppressive Agents; Keratoplasty, Penetrating; Limbus Corneae; Male; Middle Aged; Mitomycin; Mycophenolic Acid; Retrospective Studies; Stem Cells; Transplantation, Homologous; Visual Acuity | 2012 |
Combination therapy to reduce conjunctival scarring after glaucoma surgery.
Topics: Alkylating Agents; Apoptosis; Calcium Channel Blockers; Cicatrix; Conjunctival Diseases; Cyclosporine; Drug Therapy, Combination; Enzyme Inhibitors; Fibroblasts; Filtering Surgery; Glaucoma; Humans; Mitomycin; Postoperative Complications; Staurosporine; Tenon Capsule; Verapamil | 2013 |
Effect of Immunosuppressive Agents on Hepatocyte Apoptosis Post-Liver Transplantation.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Caspase 3; Cell Survival; Cyclosporine; Drug Therapy, Combination; Female; Fluorouracil; Hepatocytes; Humans; Immunosuppressive Agents; Liver; Liver Cirrhosis; Liver Transplantation; Male; Mice; Mice, Inbred C57BL; Middle Aged; Mitomycin; Semustine; Sirolimus; Tacrolimus | 2015 |
Polymeric nanocapsules: a potential new therapy for corneal wound healing.
Topics: Animals; Cornea; Corneal Injuries; Cyclosporine; Drug Carriers; Male; Mice, Inbred C57BL; Microscopy, Electron, Transmission; Mitomycin; Nanocapsules; Peptides; Protamines; Rabbits; Vitamin A; Wound Healing | 2016 |
The combination of mitomycin-induced blood cells with a temporary treatment of ciclosporin A prolongs allograft survival in vascularized composite allotransplantation.
Topics: Animals; Antibiotics, Antineoplastic; Composite Tissue Allografts; Cyclosporine; Graft Survival; Hindlimb; Immunosuppressive Agents; Leukocytes, Mononuclear; Male; Mitomycin; Models, Animal; Rats; Rats, Inbred BN; Rats, Inbred Lew; Vascularized Composite Allotransplantation | 2018 |